Begoña López Selected Research

procollagen type I carboxy terminal peptide (PICP)

6/2022	A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy.
2/2020	Does Chronic Kidney Disease Facilitate Malignant Myocardial Fibrosis in Heart Failure with Preserved Ejection Fraction of Hypertensive Origin?
1/2019	Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure.
1/2017	Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome.
4/2015	Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin.
8/2010	Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.
4/2008	Impact of collagen type I turnover on the long-term response to cardiac resynchronization therapy.
9/2007	Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Begoña López Research Topics

Disease

44	Fibrosis (Cirrhosis) 06/2022 - 05/2002
41	Heart Failure 06/2022 - 06/2004
17	Heart Diseases (Heart Disease) 01/2021 - 12/2002
14	Hypertension (High Blood Pressure) 01/2021 - 11/2003
8	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 08/2012 - 08/2004
7	Hypertrophy 08/2012 - 03/2005
6	Left Ventricular Dysfunction 06/2022 - 04/2006
6	Aortic Valve Stenosis (Aortic Stenosis) 04/2020 - 04/2014
5	Chronic Renal Insufficiency 10/2020 - 12/2008
4	Atrial Fibrillation 01/2019 - 10/2014
3	Systolic Heart Failure 10/2014 - 07/2006
3	Essential Hypertension 11/2007 - 01/2002
2	Inflammation (Inflammations) 01/2019 - 10/2011
2	Diastolic Heart Failure 10/2017 - 07/2006
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 02/2015 - 08/2010
2	Pathologic Processes 08/2012 - 04/2005
1	Neoplasms (Cancer) 06/2022
1	Cardiotoxicity 06/2022
1	Breast Neoplasms (Breast Cancer) 06/2022
1	Ventricular Remodeling 01/2019
1	Pathologic Constriction (Stenosis) 12/2016
1	Type 2 Diabetes Mellitus (MODY) 04/2015
1	Myocardial Infarction 01/2014
1	Kidney Diseases (Kidney Disease) 11/2013
1	Microvascular Rarefaction 10/2011
1	Cardiomyopathies (Cardiomyopathy) 01/2011
1	Wounds and Injuries (Trauma) 07/2010

Drug/Important Bio-Agent (IBA)

34	CollagenIBA 01/2022 - 05/2002
33	Biomarkers (Surrogate Marker)IBA 06/2022 - 08/2004
15	Collagen Type I (Type I Collagen)IBA 01/2022 - 11/2003
11	Procollagen Type IIBA 01/2022 - 08/2005
8	procollagen type I carboxy terminal peptide (PICP)IBA 06/2022 - 09/2007
7	Angiotensin IIIBA 01/2020 - 01/2002
6	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2017 - 02/2009
6	CytokinesIBA 08/2012 - 03/2005
5	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 03/2014
5	Torsemide (Demadex)FDA LinkGeneric 01/2018 - 06/2004
5	Antihypertensive Agents (Antihypertensives)IBA 12/2005 - 12/2002
4	Proteins (Proteins, Gene)FDA Link 10/2020 - 10/2007
4	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 02/2020 - 03/2004
4	Peptides (Polypeptides)IBA 09/2017 - 08/2005
4	MicroRNAs (MicroRNA)IBA 01/2017 - 04/2014
4	EnzymesIBA 01/2017 - 03/2004
3	Spironolactone (Aldactone)FDA LinkGeneric 01/2022 - 01/2018
3	Collagen Type III (Type III Collagen)IBA 01/2019 - 03/2014
3	SaltsIBA 01/2019 - 04/2006
3	Troponin T (Troponin T1)IBA 01/2019 - 12/2016
3	Furosemide (Lasix)FDA LinkGeneric 01/2018 - 06/2004
3	Losartan (Cozaar)FDA LinkGeneric 01/2017 - 05/2002
3	Tissue Inhibitor of Metalloproteinase-1IBA 01/2016 - 06/2010
2	Galectin 3 (LGALS3)IBA 01/2021 - 04/2015
2	Matrix Metalloproteinases (MMPs)IBA 02/2020 - 03/2004
2	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2019 - 04/2015
2	GadoliniumIBA 01/2018 - 08/2010
2	CreatinineIBA 09/2017 - 03/2009
2	Connective Tissue Growth FactorIBA 01/2017 - 11/2013
2	pro-brain natriuretic peptide (1-76)IBA 12/2016 - 02/2009
2	OsteopontinIBA 01/2016 - 07/2013
2	Messenger RNA (mRNA)IBA 11/2013 - 10/2007
2	NADPH Oxidases (NAD(P)H oxidase)IBA 11/2013 - 01/2012
2	Superoxides (Superoxide)IBA 11/2013 - 01/2012
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2011 - 03/2006
2	Natriuretic PeptidesIBA 03/2009 - 02/2009
2	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 12/2008 - 06/2004
2	Atenolol (Tenormin)FDA LinkGeneric 09/2007 - 08/2004
2	Fibrillar CollagensIBA 03/2004 - 12/2002
1	AnthracyclinesIBA 06/2022
1	ProcollagenIBA 06/2022
1	citrus pectinIBA 01/2021
1	Insulin-Like Growth Factor Binding Protein 2IBA 10/2020
1	lycorineIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Histones (Histone)IBA 01/2020
1	Amphibian VenomsIBA 01/2020
1	AlkaloidsIBA 01/2020
1	SteroidsIBA 01/2020
1	bufalinIBA 01/2020
1	Mineralocorticoid Receptor AntagonistsIBA 01/2019
1	Fibroblast Growth Factor-23IBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	PlasticsIBA 01/2018
1	ProteomeIBA 09/2017
1	losartan carboxylic acidIBA 01/2017
1	2- butyl- 4- chloro- 1- ((2'- (1H- tetrazol- 5- yl)(1,1'- biphenyl)- 4- yl)methyl)- 1H- imidazole- 5- carboxaldehydeIBA 01/2017
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2017
1	CalciumIBA 10/2016
1	Cystatin CIBA 01/2016
1	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2015
1	Diltiazem (Cardizem)FDA LinkGeneric 02/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2014
1	ConnectinIBA 11/2013
1	OSM-LIF ReceptorsIBA 08/2012
1	Interleukin-6 (Interleukin 6)IBA 08/2012
1	DNA (Deoxyribonucleic Acid)IBA 05/2011
1	collagen type I trimeric cross-linked peptideIBA 08/2010
1	Insulin (Novolin)FDA Link 03/2009
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2009

Therapy/Procedure

9	Therapeutics 01/2020 - 08/2004
1	Drug Therapy (Chemotherapy) 06/2022
1	Transplantation 01/2014